Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DETECT V/CHEVENDO
2014-002249-22Phase 3Completed
- Sponsor
- University Hospital Ulm
- Start
- Mar 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pertuzumab, trastuzumab and ribociclib in breast cancer (2 arms), sponsored by University Hospital Ulm. Started Mar 2015; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2014-002249-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002249-22.